Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/1/2014 |
| Start Date: | July 2012 |
| Contact: | Mike Andino |
| Email: | Mike.Andino@ppdi.com |
| Phone: | +1 855-714-0086 |
The purpose of this study is to determine whether RPC1063 is effective in the treatment of
relapsing multiple sclerosis (RMS).
relapsing multiple sclerosis (RMS).
Inclusion Criteria:
- Multiple sclerosis as diagnosed by the revised 2010 McDonald criteria
- EDSS score between 0 and 5.0 at baseline
Exclusion Criteria:
- Secondary or primary progressive multiple sclerosis
We found this trial at
10
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials